TrimRx's Blog

Mounjaro doesn’t directly cause compulsive shopping, but appetite suppression can shift reward-seeking behaviours to non-food outlets — here’s what to

Weight plateaus on Zepbound occur when metabolic adaptation matches your new caloric baseline. We explain why it happens and what changes actually work.

Mounjaro doesn’t cause gambling addiction — but GLP-1 medications may amplify compulsive behaviors in predisposed individuals. Here’s the evidence.

Zepbound plateau at 3 months happens when metabolic adaptation outpaces medication effect — typically 10–15% of patients experience this. Here’s how to

Build muscle on Zepbound by prioritizing protein intake, resistance training, and leucine-rich meals — GLP-1 therapy doesn’t stop muscle growth.

Weight loss stalls at 6 months on Zepbound are predictable, not failures. The GLP-1 receptor adaptation curve, not willpower, drives the plateau—here’s

Zepbound (tirzepatide) alters protein synthesis signaling and recovery timing — here’s how to structure training, nutrition, and dose timing for muscle

Mounjaro reduces binge eating episodes by 60–70% in clinical observations through GLP-1 and GIP receptor agonism that normalizes hunger signaling.

Mounjaro produces 3-5% body weight loss in month one through dual GIP/GLP-1 action — slower than expected but clinically significant with proper titration.